Immunoscintigraphy
 | This article possibly contains original research. (December 2022) |
| Immunoscintigraphy | |
|---|---|
| Purpose | detect cancer cells |
Immunoscintigraphy is a nuclear medicine procedure used to find cancer cells in the body by injecting a radioactively labeled antibody, which binds predominantly to cancer cells and then scanning for concentrations of radioactive emissions.[1][2]
Clinical applications
Immunoscintigraphy is performed using a variety of
capromab pendetide reacts with prostate membrane specific antigen (PMSA) and can be labelled with 111In.[4]
See also
References
- ^ "Imaging Techniques for the Diagnosis of Ovarian Cancers: Immunoscintigraphy". 21 December 2004.
- ^ "Immunoscintigraphy". NCI Dictionary of Cancer Terms. National Cancer Institute. Retrieved 1 June 2017.
- ISBN 9789057023101.
- PMID 19383333.
| X-ray/ radiography |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI | |||||||||||||
| Ultrasound | |||||||||||||
| Radionuclide |
| ||||||||||||
| Optical/Laser | |||||||||||||
| Thermography | |||||||||||||
| Target conditions |
| ||||||||||||
 | This immunology article is a stub. You can help Wikipedia by expanding it. |
 | This nuclear medicine article is a stub. You can help Wikipedia by expanding it. |